Latest News

HORIBA (TSE:6856) has been quietly building momentum, with the share price up around 16% over the past month and more than 80% over the past year. This has drawn fresh attention to its valuation. See our latest analysis for HORIBA. With the share price now around ¥15,980, HORIBA’s strong 30 day and year to date share price returns, alongside an impressive multi year total shareholder return, point to clear positive momentum as investors reassess its growth and risk profile. If HORIBA’s run...

Cracker Barrel Old Country Store (CBRL) has kicked off Q1 2026 with a backdrop of Q4 2025 revenue of about $868 million and EPS of $0.30, alongside trailing twelve month EPS of $2.08 on roughly $3.5 billion in revenue. The company has seen quarterly revenue move between about $845 million and $949 million through fiscal 2025, with EPS ranging from $0.22 to $1.00, while trailing figures show a modest uptick in net margin to 1.3% from 1.2%. Against that setup, investors will be watching how...

Recently, Dutch program Nieuwsuur reported that ASML had supplied parts to a Chinese firm allegedly linked to the country’s military, prompting the company to reiterate that all exports either fall outside licensing rules or have been cleared by the Dutch government. This raises fresh questions for investors about ASML’s exposure to geopolitics and export controls at a time when its technology is central to advanced chip manufacturing. Next, we’ll examine how heightened scrutiny of ASML’s...

AeroVironment (AVAV) just posted its latest results with Q1 2026 revenue of about $454.7 million and a basic EPS loss of roughly $1.44, while trailing twelve month figures show revenue of around $1.1 billion and basic EPS of about negative $1.37. Over the past few reported periods, revenue has moved from $196.9 million in Q4 2024 to $189.5 million, $188.5 million, $167.6 million, $275.1 million, and now $454.7 million. Over the same stretch, EPS has shifted from a $0.22 profit to $0.76,...

Daktronics (DAKT) just posted its Q2 2026 scorecard with revenue of about $219 million and basic EPS of $0.34, setting a clear marker after a volatile run of recent quarters. The company has seen revenue move from $215.9 million in Q4 2024 to a range between roughly $149.5 million and $226.1 million through 2025, while quarterly EPS has swung between a loss of $0.36 and a profit of $0.46. This leaves investors focused on how durable the latest profitability really is as margins edge forward...

Iron Mountain (IRM) is suddenly under a legal and reputational spotlight after Gotham City Research accused the company of understating leverage, inflating adjusted EBITDA, and using sharply higher, ransom like fees with customers. See our latest analysis for Iron Mountain. The short term picture has clearly turned risk off, with a 30 day share price return of minus 16.45 percent and year to date share price return of minus 18.37 percent. However, the five year total shareholder return of...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Ideally, a...

J.Jill (JILL) has just posted another steady quarter, with Q2 2026 revenue of about $154 million and basic EPS of $0.69 off net income of roughly $10.5 million, giving investors a clear snapshot of how the apparel retailer is navigating a softer same store sales backdrop. The company has seen quarterly revenue move in a relatively tight band between about $142 million and $162 million over the past six reported periods, while EPS has ranged from $0.15 to $1.17. This underscores a business...

Lucid Group (LCID) has been grinding through a tough stretch, with the stock sliding over the past month and past 3 months, even as revenue keeps growing from a small base. See our latest analysis for Lucid Group. Despite a sharp 1 day share price gain, Lucid’s 30 day share price return of minus 24.45 percent and 1 year total shareholder return of minus 46.58 percent show that momentum is still fading as investors reassess execution risks against long term EV potential. If Lucid’s volatility...

In recent months, ARGAN announced a new lease with JUNG LOGISTIQUE for a 30,000 sq.m AutOnom® logistics facility in Tournan-en-Brie and confirmed with DECATHLON the modernization of heating systems across more than 170,000 sq.m of logistics space using next-generation heat pumps. These projects underline ARGAN’s focus on pairing logistics expansion with concrete energy-efficiency upgrades, enhancing the resilience and decarbonization profile of its tenant portfolio. We’ll now examine how...

JAC Recruitment Co., Ltd. ( TSE:2124 ) will increase its dividend from last year's comparable payment on the 30th of...

In early December 2025, Amazon Web Services introduced higher-performance Graviton5-powered EC2 M9g instances and expanded its Nova AI portfolio, while partners like Dynatrace, BigID, Reply, and Perion announced deeper integrations that extend AWS’s reach across observability, security, agentic AI, and advertising. Together with Amazon’s multi-billion-dollar AI spending plans and expanded India investment roadmap, these developments highlight how AWS’s AI infrastructure and ecosystem...

If you are wondering whether Donaldson Company at around $92 is still worth considering after its strong run, or if the easy money has already been made, you are not alone and that is exactly what we are going to unpack. The stock is up 5.2% over the last week, 4.9% over the past month, and 36.9% year to date, building on multi year gains of 28.8% over 1 year, 61.3% over 3 years, and 75.6% over 5 years. Recent moves have been supported by steady demand for its filtration solutions across...

Dave & Buster's Entertainment (PLAY) has just posted another quarter of solid headline numbers, with Q2 2026 revenue of $557.4 million and basic EPS of $0.33, alongside net income of $11.4 million. The company has seen revenue move from $453 million in Q3 2025 to $534.5 million in Q4 2025, then to $567.7 million in Q1 2026 and $557.4 million in Q2 2026, while EPS swung from a loss of $0.84 in Q3 2025 to positive readings of $0.25, $0.63, and $0.33 over the subsequent quarters. With analysts...

BlackLine (BL) just switched on a new locally hosted cloud region in Saudi Arabia, a calculated move that taps into the Kingdom’s modernization push while satisfying tight data residency and cybersecurity rules. See our latest analysis for BlackLine. That Saudi expansion comes as BlackLine’s 1 month share price return of 7.18% and 3 month gain of 5.97% hint at improving sentiment, even though its 1 year total shareholder return of negative 9.74% shows the longer term picture is still one of...

Apple recently announced a major leadership reshuffle, including the upcoming retirement of general counsel Kate Adams and environment chief Lisa Jackson, and the 2026 arrival of former Meta chief legal officer Jennifer Newstead to lead a newly combined Legal and Government Affairs organization. Alongside these changes, the planned retirement of AI head John Giannandrea and Apple’s wider succession planning highlight how the company is reorganizing senior talent to support its next phase of...

Groupe Dynamite (TSX:GRGD) has just posted another upbeat quarter, with Q2 2026 revenue of about CA$326 million, Basic EPS of CA$0.59 and net income of roughly CA$63.9 million, supported by a Same Store Sales Growth figure of 28.6% that underscores ongoing momentum in the core business. The company has seen revenue move from roughly CA$239 million in Q2 2025 to CA$326 million in Q2 2026, alongside EPS climbing from about CA$0.38 to CA$0.59. This sets up a narrative in which rising sales...

DexCom (DXCM) just rolled out Dexcom Academy, a tailored learning platform for healthcare professionals that could quietly reshape how its continuous glucose monitors are used day to day and, in turn, how investors view the stock. See our latest analysis for DexCom. That launch lands at an interesting moment, with the share price at $67.55 and a 30 day share price return of 23.18% suggesting short term momentum is rebuilding, even as the 1 year total shareholder return of negative 16.06%...

Sandoz Group (SWX:SDZ) just kicked off a major European rollout of its Wyost and Jubbonti denosumab biosimilars, opening fresh exposure to a multibillion dollar cancer bone disease and osteoporosis market. See our latest analysis for Sandoz Group. The denosumab rollout lands at a strong moment for Sandoz, with a 30 day share price return of 9.77% and a 90 day share price return of 22.49% helping drive a 1 year total shareholder return of 60.6%. This suggests momentum is building as investors...

On December 8, 2025, The Macerich Company reported at the Nareit REITWorld conference in Dallas that it had achieved record leasing activity of 3.2 million square feet by the third quarter and completed US$1.20 billion in mall asset sales, alongside opening more than 300 new stores including luxury and international brands. This combination of robust leasing performance and sizable asset sales highlights how Macerich is both filling space with higher-quality tenants and actively reshaping...

TotalEnergies (ENXTPA:TTE) has been grinding higher over the past month, outpacing many European energy peers as investors reassess its mix of traditional oil assets and growing renewables exposure, with the stock still trading at a moderate valuation. See our latest analysis for TotalEnergies. At around $55.82, the recent pullback after a steady 30 day share price return of 3.29% sits against a solid 10.89% 1 year total shareholder return, suggesting momentum is cooling slightly rather than...

Earlier this month, KBRA assigned preliminary ratings to 10 classes of mortgage-backed notes from New Residential Mortgage Loan Trust 2025-NQM7, a non-prime RMBS deal sponsored by Rithm Capital and backed mainly by loans originated by NewRez LLC and Champions Funding, LLC. This latest non-prime securitization highlights Rithm’s ongoing use of capital markets to fund and recycle mortgage risk across its broader real estate credit platform. We’ll now consider how Rithm’s new non-prime RMBS...

If you are wondering whether WisdomTree is still a smart buy at around $11.69, you are not alone. This stock sits at the crossroads of growth, income, and structural change in asset management. After a 4.7% gain over the last week and a strong 15.6% return year to date, the stock has cooled slightly in the last month with a -0.3% move, while still sitting on hefty 3 year and 5 year gains of 125.2% and 162.2% respectively. Those moves have come as WisdomTree has leaned further into thematic...

BioArctic’s partner Eisai has announced that Alzheimer’s drug Leqembi (lecanemab) has been added to China’s National Healthcare Security Administration “Commercial Insurance Innovative Drug List,” expanding access to early Alzheimer’s treatment in a key market following its June 2024 launch there. This move materially enhances the commercial potential of Leqembi in China, which could be important for BioArctic given its role in the drug’s development and its ongoing commercialization...